During the past decade, Comprehensive Diabetes-Endocrine Medical Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Comprehensive Diabetes-Endocrine Medical Associates" are "Type 2 Diabetes Mellitus" (3 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (2 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Comprehensive Diabetes-Endocrine Medical Associates" in a lesser frequency.

Most popular intervention types in "Comprehensive Diabetes-Endocrine Medical Associates" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "AC2993" (4 trials), "Placebo" (3 trials), "Tirzepatide" (2 trials), "Dulaglutide" (1 trials) and "Insulin Glargine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Diabetes-Endocrine Medical Associates" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Comprehensive Diabetes-Endocrine Medical Associates". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Comprehensive Diabetes-Endocrine Medical Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Diabetes-Endocrine Medical Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".